A study evaluating the safety of a robotic angioplasty system in delivering coronary stents, balloons and other interventions has found the system as feasible, safe and effective as that of a manual operation, according to published study abstract in the Journal of the American College of Cardiology.
Eight patients with coronary artery disease and clinical indication for elective percutaneous coronary intervention were enrolled in the study. Coronary procedures were performed with CorPath 200 robotic system and patients were followed up to 30 days after.
The primary endpoint was achieved in all patients, and the technical success of the robotic system was 97.9 percent in completing 47 of 48 planned steps. There were no device- or procedure-related complications or major adverse events.
Still, the researchers say a larger study is warranted to verify the safety and effectiveness of robotic-assisted PCI.
Read the study on robotic angioplasty systems in the Journal of the American College of Cardiology.
Related Articles on Surgical Procedures:
Study: Robotic Surgery Effective for Hard-to-Reach Larynx Cancer
Heart Device Provides Alternative to Surgery
New Pelvic-Repair Device Drives Efficiency in Trauma Surgery
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
